NASDAQ:IRTC iRhythm Technologies (IRTC) Stock Price, News & Analysis $109.09 -1.28 (-1.16%) Closing price 04:00 PM EasternExtended Trading$109.09 0.00 (0.00%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About iRhythm Technologies Stock (NASDAQ:IRTC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get iRhythm Technologies alerts:Sign Up Key Stats Today's Range$106.77▼$111.3750-Day Range$109.09▼$128.5252-Week Range$100.85▼$212.00Volume626,265 shsAverage Volume514,582 shsMarket Capitalization$3.60 billionP/E RatioN/ADividend YieldN/APrice Target$180.07Consensus RatingModerate Buy Company Overview iRhythm Technologies, Inc. is a digital health care company focused on ambulatory cardiac monitoring and the diagnosis of cardiac arrhythmias. The company combines wearable biosensor technology, cloud-based data analysis and clinical services to help physicians detect and manage irregular heart rhythms, including atrial fibrillation. Its principal products include the Zio monitor portfolio, which is designed for extended, continuous electrocardiogram monitoring in an easy-to-use wearable format. iRhythm’s platform collects cardiac data outside the traditional clinical setting and uses proprietary algorithms and analysis tools to identify potentially significant events for review by health care professionals. The company also provides reporting and related support services that assist clinicians in interpreting monitoring results and making treatment decisions. Founded in 2006 and headquartered in San Francisco, iRhythm primarily serves health care providers and patients in the United States. The company has also expanded availability of its technology and services into select international markets, including the United Kingdom. iRhythm’s products are used across cardiology, primary care and other clinical settings where extended monitoring can support the evaluation of suspected or previously undiagnosed arrhythmias.AI Generated. May Contain Errors. Read More iRhythm Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks69th Percentile Overall ScoreIRTC MarketRank™: iRhythm Technologies scored higher than 69% of companies evaluated by MarketBeat, and ranked 216th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingModerate Buy Consensus RatingiRhythm Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.94, and is based on 2 strong buy ratings, 12 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialiRhythm Technologies has a consensus price target of $180.07, representing about 65.1% upside from its current price of $109.09.Amount of Analyst CoverageiRhythm Technologies has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about iRhythm Technologies' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth141.67% Earnings GrowthEarnings for iRhythm Technologies are expected to grow by 141.67% in the coming year, from $0.60 to $1.45 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of iRhythm Technologies is -253.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iRhythm Technologies is -253.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiRhythm Technologies has a P/B Ratio of 23.01. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about iRhythm Technologies' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.36% of the float of iRhythm Technologies has been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 5.56.Change versus previous monthShort interest in iRhythm Technologies has recently increased by 9.56%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldiRhythm Technologies does not currently pay a dividend.Dividend GrowthiRhythm Technologies does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.20 News SentimentiRhythm Technologies has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 10 news articles for iRhythm Technologies this week, compared to 5 articles on an average week.MarketBeat Follows1 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, iRhythm Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders0.98% of the stock of iRhythm Technologies is held by insiders.Percentage Held by InstitutionsiRhythm Technologies has minimal institutional ownership at this time.Read more about iRhythm Technologies' insider trading history. Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IRTC Stock News HeadlinesNeedham Lifts Price Target on iRhythm Technologies to $194 From $192, Keeps Buy RatingOctober 5 at 2:22 PM | marketscreener.comMiRhythm Technologies (NASDAQ:IRTC) Stock Gets Price Target Increase from Needham & Company LLCOctober 5 at 1:01 PM | americanbankingnews.comReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.October 5 at 1:00 AM | Base Camp Trading (Ad)iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home CareOctober 5 at 9:05 AM | globenewswire.comIRhythm Begins Notifying Patients Following Review Of Cybersecurity IncidentOctober 4 at 11:53 AM | rttnews.comiRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026October 2 at 4:41 PM | globenewswire.comiRhythm Technologies (NASDAQ:IRTC) Receives Consensus Rating of "Moderate Buy" from AnalystsOctober 1, 2026 | americanbankingnews.comAnalysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC) and Capricor Therapeutics (CAPR)September 30, 2026 | theglobeandmail.comSee More Headlines IRTC Stock Analysis - Frequently Asked Questions How have IRTC shares performed this year? iRhythm Technologies' stock was trading at $177.44 at the start of the year. Since then, IRTC stock has decreased by 38.5% and is now trading at $109.09. How were iRhythm Technologies' earnings last quarter? iRhythm Technologies (NASDAQ:IRTC) released its quarterly earnings data on Thursday, August, 6th. The company reported $0.58 EPS for the quarter, topping analysts' consensus estimates of ($0.04) by $0.62. iRhythm Technologies's revenue for the quarter was up 20.1% on a year-over-year basis. Read the conference call transcript. When did iRhythm Technologies IPO? iRhythm Technologies (IRTC) raised $88 million in an initial public offering on Thursday, October 20th 2016. The company issued 6,294,118 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. Who are iRhythm Technologies' major shareholders? iRhythm Technologies' top institutional shareholders include Versant Capital Management Inc. Insiders that own company stock include Quentin S Blackford, Mark J Day, Patrick Michael Murphy, Chad Patterson, Minang Turakhia, Sumi Shrishrimal, Daniel G Wilson, Mervin Smith, Abhijit Y Talwalkar, Brice Bobzien, Marc Wade Rosenbaum and Marc W Rosenbaum. View institutional ownership trends. How do I buy shares of iRhythm Technologies? Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iRhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that iRhythm Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), Arista Networks (ANET) and ServiceNow (NOW). Company Calendar Last Earnings8/06/2026Today10/05/2026Next Earnings (Estimated)10/29/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (6m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 IRTC's financial health is in the Red zone, according to TradeSmith. IRTC has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:IRTC CIK1388658 Webwww.irhythmtech.com Phone(415) 632-5700FaxN/AEmployees2,400Year Founded2006Price Target and Rating Average Price Target for iRhythm Technologies$180.07 High Price Target$220.00 Low Price Target$147.00 Potential Upside/Downside+65.1%Consensus RatingModerate Buy Rating Score (0-4)2.94 Research Coverage16 Analysts Profitability EPS (Trailing Twelve Months)($0.43) Trailing P/E RatioN/A Forward P/E Ratio181.82 P/E GrowthN/ANet Income-$44.55 million Net Margins-1.69% Pretax Margin-1.57% Return on Equity10.11% Return on Assets1.53% Debt Debt-to-Equity Ratio3.50 Current Ratio3.86 Quick Ratio3.74 Sales & Book Value Annual Sales$747.14 million Price / Sales4.81 Cash FlowN/A Price / Cash FlowN/A Book Value$4.74 per share Price / Book23.01Miscellaneous Outstanding Shares32,960,000Free Float32,640,000Market Cap$3.60 billion OptionableOptionable Beta1.45 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:IRTC) was last updated on 10/5/2026 by MarketBeat.com Staff. From Our PartnersThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredElon Musk’s Hushed FCC Filing. Dec 8th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
